Human Cripto-1 as a target for a cancer vaccine: WO2008040759. - Test2 - elhamkhani - TriplyDB

Human Cripto-1 as a target for a cancer vaccine: WO2008040759.

Human Cripto-1 as a target for a cancer vaccine: WO2008040759.

http://www.wikidata.org/entity/Q37481287

about

Targeting the embryonic gene Cripto-1 in cancer and beyond.Cripto-1 expression in glioblastoma multiforme.

P2860

Q34688767-B8EDE486-5F0D-4DB9-B74C-86DB0B516155 Q39024553-76CD1F33-6B93-4BFD-A842-C6744DA3B55A

P2860

Human Cripto-1 as a target for a cancer vaccine: WO2008040759.

http://www.wikidata.org/entity/Q37481287

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Human Cripto-1 as a target for a cancer vaccine: WO2008040759.

@en

Human Cripto-1 as a target for a cancer vaccine: WO2008040759.

@nl

type

label

Human Cripto-1 as a target for a cancer vaccine: WO2008040759.

@en

Human Cripto-1 as a target for a cancer vaccine: WO2008040759.

@nl

prefLabel

Human Cripto-1 as a target for a cancer vaccine: WO2008040759.

@en

Human Cripto-1 as a target for a cancer vaccine: WO2008040759.

@nl

P1433

Q37481287-54195E76-B433-4D5A-B08B-9F27A806D9B1

P1476

Q37481287-2CDF2931-4834-48C8-BD22-F0B0A7671FA9

P2093

Q37481287-6F7A480E-8666-43DA-8266-686322E7FDAC

Q37481287-8120DE83-0D5F-4FEC-B058-22AFA1E0C6BF

P2860

Q37481287-389C6CE7-C52B-488B-910A-4282FB779F99

Q37481287-42A92151-DA64-4E08-84B2-44776431DDC7

Q37481287-43965CFD-4112-419E-9F56-F707421EEBE1

Q37481287-5813A5A2-248C-4D09-ABC9-A6E2BD10C844

Q37481287-5881C0BA-18AA-4491-867A-35F0516C43AA

Q37481287-7E2DC40F-9F2F-46A7-B4F5-5B3D949FE53A

Q37481287-801AA997-3C8F-4696-822F-3B951C3E3526

Q37481287-9CCB7AFC-FEFA-4A42-A6C1-8091E705002C

Q37481287-A0731EEC-9E85-478C-8306-8408D782DBAF

Q37481287-A0B4E5E2-1DAF-4ADE-B734-C755755A691A

P304

Q37481287-5C566373-F938-4550-9C1C-E9C1C379C4C5

P31

Q37481287-BB3C5FFA-7BCC-465F-A86E-6AF74A158AD0

P356

Q37481287-AAB8114E-720C-4CAB-9ECB-4A87C8CD5671

P407

Q37481287-0B3A12CC-C712-4C64-A26B-13B10B95C106

P433

Q37481287-43775EFB-2F84-4391-BE32-E15EF1774E31

P478

Q37481287-33E8D37C-E597-47ED-AC1A-0238FD57A297

P577

Q37481287-160BF391-C089-4776-8587-8323F17E2337

P698

Q37481287-3907BD21-5D4B-4E40-B036-F97F9464740D

P356

13543770802646956

P1433

Expert Opinion on Therapeutic Patents

P1476

Human Cripto-1 as a target for a cancer vaccine: WO2008040759.

@en

P2093

Caterina Bianco

http://www.w3.org/2001/XMLSchema#string

David S Salomon

http://www.w3.org/2001/XMLSchema#string

P2860

Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial Cells

Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo

The role of EGF-related peptides in tumor growth.

Nodal signaling in vertebrate development.

Cripto forms a complex with activin and type II activin receptors and can block activin signaling

Role of the cripto (EGF-CFC) family in embryogenesis and cancer.

Cripto as a target for cancer immunotherapy.

Cripto-1: an oncofetal gene with many faces.

Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis.

Anti-Cripto Mab inhibit tumour growth and overcome MDR in a human leukaemia MDR cell line by inhibition of Akt and activation of JNK/SAPK and bad death pathways.

P304

141-144

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543770802646956

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19441915

http://www.w3.org/2001/XMLSchema#string